Hydroalcoholic Extract of Myrcia bella Loaded into a Microemulsion System: A Study of Antifungal and Mutagenic Potential

Abstract

Myrcia bella is a medicinal plant used for the treatment of diabetes, hemorrhages, and hypertension in Brazilian folk medicine. Considering that plant extracts are attractive sources of new drugs, the aim of the present study was to verify the influence of incorporating 70% hydroalcoholic of M. bella leaves in nanostructured lipid systems on the mutagenic and antifungal activities of the extract. In this work, we evaluated the antifungal potential of M. bella loaded on the microemulsion against Candida sp for minimum inhibitory concentration, using the microdilution technique. The system was composed of polyoxyethylene 20 cetyl ether and soybean phosphatidylcholine (10%), grape seed oil, cholesterol (10%: proportion 5/1), and purified water (80%). To investigate the mutagenic activity, the Ames test was used with the Salmonella Typhimurium tester strains. M. bella, either incorporated or free, showed an important antifungal effect against all tested strains. Moreover, the incorporation surprisingly inhibited the mutagenicity presented by the extract. The present study attests the antimicrobial properties of M. bella extract, contributing to the search for new natural products with biological activities and suggesting caution in its use for medicinal purposes. In addition, the results emphasize the importance of the use of nanotechnology associated with natural products as a strategy for the control of infections caused mainly by the genus Candida sp.

Key words

Myrcia bella - Myrtaceae - biopharmaceuticals - biotechnology - antifungal - nanotechnology - mutagenicity

Publication History

Received: 26 August 2020

Accepted after revision: 23 November 2020

Article published online:
28 January 2021

• References

• 1 Fisher MC, Hawkins NJ, Sanglard D, Gurr SJ. Worldwide emergence of resistance to antifungal drugs challenges human health and food security. Science 2018; 360: 739-742
• 2 Aminov RI. A brief history of the antibiotic era: lessons learned and challenges for the future. Front Microbiol 2010; 1: 134 doi:10.3389/fmicb.2010.00134
• 3 Geddes-McAlister J, Shapiro RS. New pathogens, new tricks: emerging, drug-resistant fungal pathogens and future prospects for antifungal therapeutics. Ann N Y Acad Sci 2019; 1435: 57-78
• 4 Gilani AH, Rahman A. Trends in ethnopharmocology. J Ethnopharmacol 2005; 100: 43-49
• 5 Cascaes MM, Guilhon GM, de Aguiar Andrade EH, das Graças Bichara Zoghbi M, da Silva Santos L. Constituents and pharmacological activities of Myrcia (Myrtaceae): a review of an aromatic and medicinal group of plants. Int J Mol Sci 2015; 16: 23881-23904
• 6 Cruz AVM, Kaplan MAC. Uso medicinal de espécies das famílias Myrtaceae e Melastomataceae no Brasil (Medicinal use of Myrtaceae and Melastomataceae species in Brazil). Floresta Ambient 2004; 11: 47-52
• 7 Vasconcelos TN, Proença CE, Ahmad B, Aguilar DS, Aguilar R, Amorim BS, Campbell K, Costa IR, De-Carvalho PS, Faria JEQ, Giaretta A, Kooij PW, Lima DF, Mazine FF, Peguero B, Prenner G, Santos MF, Soewarto J, Wingler A, Lucas E. Myrteae phylogeny, calibration, biogeography and diversification patterns: increased understanding in the most species rich tribe of Myrtaceae. Mol Phylogenet Evol 2017; 109: 113-137
• 8 Vareda PMP, Saldanha LL, Camaforte NAP, Violato NM, Dokkedal AL, Bosqueiro JR. Myrcia bella leaf extract presents hypoglycemic activity via PI3k/Akt insulin signaling pathway. Evid Based Complement Alternat Med 2014; 2014: 543606
• 9 Serpeloni JM, Specian AFL, Ribeiro DL, Tuttis K, Vilegas W, Martínez-López W, Dokkedal AL, Saldanha LL, Cólus IMS, Varanda EA. Antimutagenicity and induction of antioxidant defense by flavonoid rich extract of Myrcia bella Cambess. in normal and tumor gastric cells. J Ethnopharmacol 2015; 176: 345-355
• 10 Santos C, Galaverna RS, Angolini CFF, Nunes VVA, Almeida LFR, Ruiz ALTG, Carvalho JE, Duarte RMT, Duarte MCT, Eberlin MN. Antioxidative, antiproliferative and antimicrobial activities of phenolic compounds from three Myrcia species. Molecules 2018; 23: 986
• 11 Saldanha LL, Vilegas W, Dokkedal AL. Characterization of flavonoids and phenolic acids in Myrcia bella cambess. Using FIA-ESI-IT-MSn and HPLC-PAD-ESI-IT-MS combined with NMR. Molecules 2013; 18: 8402-8416
• 12 Saldanha LL, Allard PM, Afzan A, Melo FPSR, Marcourt L, Queiroz EF, Vilegas W, Furlan CM, Dokkedal AL, Wolfender JL. Metabolomics of Myrcia bella populations in Brazilian savanna reveals strong influence of environmental factors on its specialized metabolism. Molecules 2020; 25: 2954
• 13 Bonifácio BV, Ramos MAS, Silva PB, Negri KMS, Lopes EO, Souza LP, Vilegas W, Pavan FR, Chorilli M, Bauab TM. Nanostructured lipid system as a strategy to improve the anti-Candida albicans activity of Astronium sp. Int J Nanomedicine 2015; 10: 5081-5092
• 14 Gupta S, Moulik SP. Biocompatible microemulsions and their prospective uses in drug delivery. J Pharm Sci 2008; 97: 22-45
• 15 Thakare M, Israel B, Garner S, Ahmed H, Elder D, Capomacchia A. Nonionic surfactant structure on the drug release, formulation and physical properties of ethylcellulose microspheres. Pharm Dev Technol 2017; 22: 418-425
• 16 Lawrence MJ, Rees GD. Microemulsion-based media as novel drug delivery systems. Adv Drug Deliv Rev 2000; 45: 89-121
• 17 Formariz TP, Urban MCC, da Silva AA, Gremião MPD, Oliveira AG. Microemulsões e fases líquidas cristalinas como sistemas de liberação de fármacos. Braz J Pharm Sci 2005; 41: 301-313
• 18 Goyal U, Arora R, Aggarwal G. Formulation design and evaluation of a self-microemulsifying drug delivery system of lovastatin. Acta Pharm 2012; 62: 357-370
• 19 Obeidat WM, Schwabe K, Müller RH, Keck CM. Preservation of nanostructured lipid carriers (NLC). Eur J Pharm Biopharm 2010; 76: 56-67
• 20 Silva PB, Freitas ES, Bernegossi J, Gonçalez ML, Sato MR, Leite CQF, Pavan FR, Chorilli M. Nanotechnology-based drug delivery systems for treatment of tuberculosis–a review. J Biomed Nanotechnol 2016; 12: 241-260
• 21 Kucharíková S, Tournu H, Lagrou K, van Dijck P, Bujdáková H. Detailed comparison of Candida albicans and Candida glabrata biofilms under different conditions and their susceptibility to caspofungin and anidulafungin. J Med Microbiol 2011; 60: 1261-1269
• 22 Lim CSY, Rosli R, Seow HF, Chong PP. Candida and invasive candidiasis: back to basics. Eur J Clin Microbiol Infect Dis 2012; 31: 21-31
• 23 Merenstein D, Hu H, Wang C, Hamilton P, Blackmon M, Chen H, Calderone R, Li D. Colonization by Candida species of the oral and vaginal mucosa in HIV-infected and noninfected women. AIDS Res Hum Retroviruses 2013; 29: 30-34
• 24 Moretti ML, Trabasso P, Lyra L, Fagnani R, Resende MR, De Oliveira Cardoso LG, Schreiber AZ. Is the incidence of candidemia caused by Candida glabrata increasing in Brazil? Five-year surveillance of Candida bloodstream infection in a university reference hospital in southeast Brazil. Med Mycol 2013; 51: 225-230
• 25 Carneiro NS, Alves CCF, Alves JM, Egea MB, Martins CHG, Silva TS, Bretanha LC, Balleste MP, Micke GA, Silveira EV, Miranda MLD. Chemical composition, antioxidant and antibacterial activities of essential oils from leaves and flowers of Eugenia klotzschiana Berg (Myrtaceae). An Acad Bras Cienc 2017; 89: 1907-1915
• 26 Caparroz-Assef SM, Grespan R, Freire Batista RC, Bersani-Amado FA, Baroni S, Araujo Dantas J, Cuman RKN, Bersani-Amado CA. Toxicity studies of Cordia salicifolia extract. Acta Sci Health Sci 2005; 27: 41-44
• 27 Ahmed AS, Elgorashi EE, Moodley N, McGaw LJ, Naidoo V, Eloff JN. The antimicrobial, antioxidative, anti-inflammatory activity and cytotoxicity of different fractions of four South African Bauhinia species used traditionally to treat diarrhoea. J Ethnopharmacol 2012; 143: 826-839
• 28 Oliveira AG, Scarpa MV, Correa MA, Rodrigues Cera LF, Formariz TP. Microemulsões: Estrutura e aplicações como sistema de liberação de fármacos. Quim Nova 2004; 27: 131-138
• 29 Clinical & Laboratory Standards Institute (CLSI). M27-A3: Reference Method for Broth Dilution antifungal Susceptibility Testing of Yeasts; Approved Standard – Third Edition. Wayne, PA: Clinical and Laboratory Standards Institute; 2008
• 30 Duarte MCT, Figueira GM, Sartoratto A, Rehder VLG, Delarmelina C. Anti-Candida activity of Brazilian medicinal plants. J Ethnopharmacol 2005; 97: 305-311
• 31 Maron DM, Ames BN. Revised methods for the Salmonella mutagenicity test. Mutat Res 1983; 113: 173-215
• 32 Bernstein L, Kaldor J, McCann J, Pike MC. An empirical approach to the statistical analysis of mutagenesis data from the Salmonella test. Mutat Res 1982; 97: 267-281
• 33 Resende FA, Vilegas W, Santos LC, Varanda EA. Mutagenicity of flavonoids assayed by bacterial reverse mutation (Ames) test. Molecules 2012; 17: 5255-5268